Published in Int J Cancer on December 01, 2001
Human embryonic stem cells as models for trophoblast differentiation. Placenta (2007) 1.11
Model systems for studying trophoblast differentiation from human pluripotent stem cells. Cell Tissue Res (2012) 1.05
Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers. Chin J Cancer (2012) 1.01
Tumor formation via loss of a molecular motor protein. Curr Biol (2006) 0.97
Identification of signaling pathways mediating cell cycle arrest and apoptosis induced by Porphyromonas gingivalis in human trophoblasts. Infect Immun (2012) 0.83
Microarray analysis on gene regulation by estrogen, progesterone and tamoxifen in human endometrial stromal cells. Int J Mol Sci (2015) 0.80
Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line. World J Gastroenterol (2005) 0.79
ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts. Cell Adh Migr (2015) 0.78
IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells. Reprod Biol Endocrinol (2014) 0.76
Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res (1993) 3.59
Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science (1989) 1.96
Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol (2001) 1.85
Evaluation of the mode of cell death in Ehrlich ascites tumor. Cancer (1972) 1.77
Molecular cloning and expression of peptide 23, a growth hormone-releasing hormone-inducible pituitary protein. Endocrinology (1995) 1.63
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer (2001) 1.61
Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol (1998) 1.41
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2. Lancet (1992) 1.40
Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res (1995) 1.40
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer (2006) 1.39
Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol Endocrinol (1990) 1.37
Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta (1998) 1.30
Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod (1992) 1.30
Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab (2001) 1.29
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. Br J Cancer (2007) 1.24
Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta (2003) 1.22
Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol (1999) 1.22
Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway. J Clin Endocrinol Metab (2001) 1.16
Monoclonal origin of B lymphocyte colony-forming cells in spleen colonies formed by multipotential hemopoietic stem cells. J Exp Med (1978) 1.16
Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res (1989) 1.11
Mechanism of control of trophoblast invasion in situ. J Cell Physiol (1991) 1.09
Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer (1999) 1.08
Maturation of B lymphocytes. I. Concurrent appearance of increasing Ig, Ia, and mitogen responsiveness. J Immunol (1979) 1.08
Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int J Cancer (2000) 1.08
Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol (1988) 1.06
Localization of H-2 antigens on mouse trophoblast cells. J Exp Med (1979) 1.06
Immunobiology of the feto-maternal interface. Immunol Rev (1983) 1.05
Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol (1986) 1.05
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling. Neuroscience (2011) 1.05
Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol (1993) 1.04
Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res (1998) 1.04
Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology (2008) 1.03
Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leukoc Biol (1988) 1.01
Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst (1992) 1.00
Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun (2001) 0.99
Characterization of maternal small lymphocyte subsets during allogeneic pregnancy in the mouse. Cell Immunol (1980) 0.99
Catechol estrogen formation in the mouse uterus and its role in implantation. Mol Cell Endocrinol (1990) 0.98
Life history of decidual cells: a review. Am J Reprod Immunol (1983) 0.97
Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta (1995) 0.97
The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. J Neurochem (2005) 0.96
Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int J Cancer (1989) 0.96
Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy. Mol Reprod Dev (1992) 0.95
RNA interference: potential therapeutic targets. Appl Microbiol Biotechnol (2004) 0.95
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice. Br J Cancer (1996) 0.95
MHC antigens on mouse trophoblast cells: paucity of Ia antigens despite the presence of H-2K and D. J Immunol (1981) 0.95
Measurement of S period in growing cell populations by a graphic analysis of double labeling with 3H- and 14C-thymidine. Exp Cell Res (1968) 0.95
Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res (1994) 0.94
Suppression of lymphocyte alloreactivity by early gestational human decidua. I. Characterization of suppressor cells and suppressor molecules. Cell Immunol (1988) 0.94
Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2. J Exp Med (1987) 0.93
Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int J Cancer (1985) 0.93
Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity. Cell Immunol (1985) 0.92
Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta (1995) 0.92
Human placental trophoblast as an in vitro model for tumor progression. Can J Physiol Pharmacol (2002) 0.92
PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cell Immunol (1989) 0.92
Localization of paternal H-2K antigens on murine trophoblast cells in vivo. J Exp Med (1982) 0.91
HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Mol Hum Reprod (2005) 0.89
Characterization of urokinase receptor expression by human placental trophoblasts. Blood (1992) 0.89
Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome. Cancer Metastasis Rev (1998) 0.89
Characterization of hematogenous cellular constituents of the murine decidua: a surface marker study. J Reprod Immunol (1985) 0.87
Bone marrow origin of decidual cell precursors in the pseudopregnant mouse uterus. J Exp Med (1982) 0.87
SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta. Int J Cancer (1998) 0.87
Interleukin-1 stimulates human chorionic gonadotropin secretion by first trimester human trophoblast. J Clin Endocrinol Metab (1989) 0.86
Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod (1998) 0.85
Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood. Immunology (1978) 0.85
Post-mitotic age of monocuclear cells migrating into TA-3(St) solid tumors. Cell Tissue Kinet (1977) 0.85
Spontaneous fusion between Ehrlich ascites tumor cells and host cells in vivo: kinetics of hybridization, and concurrent changes in the histocompatiblity profile of the tumor after propagation in different host strains. Eur J Cancer (1980) 0.84
Prostaglandin-mediated inactivation of natural killer cells in the murine decidua. Cell Immunol (1990) 0.84
Age-specific changes in the proliferation of Ehrlich ascites tumor cells grown as solid tumors. Cancer Res (1972) 0.84
Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer (2001) 0.84
Maturation of B lymphocytes. II. Sequential appearance of increasing IgM and IgD in the adult bone marrow. Eur J Immunol (1979) 0.83
Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: growth pattern, markers, and hormone production. Am J Obstet Gynecol (1989) 0.83
Decidual cell-specific surface antigen(s) recognized by monoclonal antibodies: tissue and species distribution. J Immunol (1985) 0.83
Hemopoietic redistribution in tumor-bearing mice. Exp Hematol (1978) 0.82
Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. Cell Immunol (1985) 0.82
Dynamics of leukocyte migration into the mouse ascites tumor. Cell Tissue Kinet (1974) 0.82
Down-regulation of macrophage I-A expression in tumor-bearing mice. J Leukoc Biol (1990) 0.81
Immunobiology of the decidual tissue. Contrib Gynecol Obstet (1985) 0.81
Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs. Int J Cancer (1980) 0.81
Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunol Immunother (1996) 0.81
Characterization of macrophage subsets regulating murine natural killer cell activity. J Leukoc Biol (1990) 0.81
Quantitative microscopy approach for shape-based erythrocytes characterization in anaemia. J Microsc (2012) 0.81
Future prospects of nanoparticles on brain targeted drug delivery. J Neurooncol (2008) 0.80
Induction of transforming growth factor-alpha gene expression in rat decidua is independent of the conceptus. Biol Reprod (1992) 0.80
Surface markers of small lymphocytes appearing in murine TA-3(St) solid tumors, host spleen, and blood. J Natl Cancer Inst (1977) 0.80
Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2. Clin Exp Metastasis (1992) 0.80
Mechanisms of cellular invasiveness: a comparison of amnion invasion in vitro and metastatic behavior in vivo. J Natl Cancer Inst (1989) 0.79
Effects of tumor bearing on the dynamics of host hemopoietic cells. Cancer Treat Rep (1976) 0.79
In situ localization and characterization of bone marrow-derived cells in the decidua of normal murine pregnancy. Biol Reprod (1992) 0.79
The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice. Lab Invest (1997) 0.79
Immunological role of the cellular constituents of the decidua in the maintenance of semiallogeneic pregnancy. Ann N Y Acad Sci (1986) 0.79
An analysis of host T-cell subsets based on Lyt antigenic markers during the development of spontaneous C3H mammary carcinomas. Cell Immunol (1984) 0.79
Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy. J Immunol (1983) 0.79